Compare Herbalife Nutrition Ltd (HLF) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Herbalife Nutrition Ltd vs McKesson Corporation — how do they compare? Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B), while McKesson Corporation trades at $938.84 (market cap $108.46B). The key difference: McKesson Corporation is far larger — about 80.9× Herbalife Nutrition Ltd's market cap, and McKesson Corporation pays a 0.4% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Herbalife Nutrition Ltd for 43 Days and McKesson Corporation for 74 Days on average.
| HLF | MCK | |
|---|---|---|
Market Cap | $1.34B | $108.46B |
Volume | 1,589,457 | 712,607 |
Sector | Consumer Staples | Health |
52-Week High | $19.96 | $995.69 |
52-Week Low | $7.75 | $725.17 |
Typical Hold Time | 43 Days | 74 Days |
Enterprise Value | $3.18B | $115.00B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Herbalife (HLF) trades at $12.82, up 1.34% on the day, with a bullish technical signal from moving averages and oscillators. The company reported Q2 2026 EPS of $0.51, missing the $0.536 estimate, but Q1 2026 beat expectations. Revenue for 2025 was $5.04 billion with a net income margin of 4.53%. Recent news includes a $250 million share repurchase program and a planned CEO transition effective October 31, 2026.
HLF presents a mixed outlook; its low P/E of 8.22 and P/S of 0.26 suggest undervaluation, but negative shareholder equity and high debt pose risks. Analyst consensus is bullish with a $19.00 price target, implying significant upside, though earnings misses and leadership changes warrant caution for investors seeking stability.
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Herbalife Nutrition Ltd
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
